心肺复苏过程中IL-8\S-100\神经元特异性烯醇酶的动态观察及研究(2)
参见附件。
[5] 孙卫民，王慧琴. 细胞因子研究方法学[M]. 北京：人民卫生出版社，1999，443-453.
[6] Green LL，Hardy MC，Maynard-Currie CE，et al. Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain[J]. Not Cenet，1994，7(1)：13-21.
[7] Donato R. Functional roles of S-100 proteins，calcium-binding proteins of the EF-hand type[J]. Bioch im Biophys Acta，1999，1450(3)：191-231.
[8] Bottiger BW，Mobes S，Glatzer R，et al. Astroglial protein S-100 is an early and sensitive marker of hypoxic brain damage and outcome after cardiac arrest in humans[J]. Circulation，2001，103(22)：2694-2698.
[9] Pfeifer R，Borner A，Krack A，et al. Outcome after cardiac arrest：predictive values and limitations of the neuroproteins neuron-specific enolase and protein S-100 and the Glasgow Coma Scale[J]. Resuscitation，2005，65(1)：49-55.
[10] Oh SH，Lee JG，Na SJ，et al. Prediction of early clinical severity and extent of neuronal damage in anterior-circulation infarction using the initial serum neuron-specific enolase level[J]. Arch Neurol，2003，60(1)：37-41.
[11] Schoerkhuber W，Kittler H，Sterz F，et al. Time course of serum neuron-specific enolase：a predictor of neurological outcome in patients resuscitated from cardiac arrest[J]. Stroke，1999，30(8)：1598-1603.
[12] Fogel W，Krieger D，Veith M，et al. Serum neuron-specific enolase as early predictor of outcome after cardiac arrest[J]. Crit Care Med，1997，25(7)：1133-1138.
[13] Hans P，Bonhomme V，Collette J，et al. Neuron-specific enolase as a marker of in vitro neuronal damage. Part 1：Assessment of neuron-specific enolase as a quantitive and specific marker of neuronal damage[J]. J Neurosurg Anesthesiol，1993，5(2)：111-116.
[14] Schaarschmidt H，Prange HW，Rriber H. Neuron-specific enolase cocentrations in blood as a prognostic parameter in cerebrovascular diseases[J]. Stroke，1994，25(3)：558-565.
(收稿日期：2011-02-14)
[5] 孙卫民，王慧琴. 细胞因子研究方法学[M]. 北京：人民卫生出版社，1999，443-453.
[6] Green LL，Hardy MC，Maynard-Currie CE，et al. Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain[J]. Not Cenet，1994，7(1)：13-21.
[7] Donato R. Functional roles of S-100 proteins，calcium-binding proteins of the EF-hand type[J]. Bioch im Biophys Acta，1999，1450(3)：191-231.
[8] Bottiger BW，Mobes S，Glatzer R，et al. Astroglial protein S-100 is an early and sensitive marker of hypoxic brain damage and outcome after cardiac arrest in humans[J]. Circulation，2001，103(22)：2694-2698.
[9] Pfeifer R，Borner A，Krack A，et al. Outcome after cardiac arrest：predictive values and limitations of the neuroproteins neuron-specific enolase and protein S-100 and the Glasgow Coma Scale[J]. Resuscitation，2005，65(1)：49-55.
[10] Oh SH，Lee JG，Na SJ，et al. Prediction of early clinical severity and extent of neuronal damage in anterior-circulation infarction using the initial serum neuron-specific enolase level[J]. Arch Neurol，2003，60(1)：37-41.
[11] Schoerkhuber W，Kittler H，Sterz F，et al. Time course of serum neuron-specific enolase：a predictor of neurological outcome in patients resuscitated from cardiac arrest[J]. Stroke，1999，30(8)：1598-1603.
[12] Fogel W，Krieger D，Veith M，et al. Serum neuron-specific enolase as early predictor of outcome after cardiac arrest[J]. Crit Care Med，1997，25(7)：1133-1138.
[13] Hans P，Bonhomme V，Collette J，et al. Neuron-specific enolase as a marker of in vitro neuronal damage. Part 1：Assessment of neuron-specific enolase as a quantitive and specific marker of neuronal damage[J]. J Neurosurg Anesthesiol，1993，5(2)：111-116.
[14] Schaarschmidt H，Prange HW，Rriber H. Neuron-specific enolase cocentrations in blood as a prognostic parameter in cerebrovascular diseases[J]. Stroke，1994，25(3)：558-565.
(收稿日期：2011-02-14)
您现在查看是摘要介绍页，详见PDF附件。